Chemomab Therapeutics (CMMB) Cash from Operations Growth (1y) (2018 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 34.82% |
| Sep 30, 2023 | 0.63% |
| Jun 30, 2023 | -31.31% |
| Mar 31, 2023 | -93.64% |
| Dec 31, 2022 | -97.06% |
| Sep 30, 2022 | -103.68% |
| Jun 30, 2022 | -1.68% |
| Mar 31, 2022 | -187.01% |
| Dec 31, 2021 | -86.11% |
| Sep 30, 2021 | -186.35% |
| Jun 30, 2021 | -542.27% |
| Mar 31, 2021 | 32.41% |
| Dec 31, 2020 | 73.71% |
| Sep 30, 2020 | 74.31% |
| Jun 30, 2020 | 77.70% |
| Mar 31, 2020 | 38.73% |
| Dec 31, 2019 | -67.96% |
| Sep 30, 2019 | 47.08% |
| Jun 30, 2019 | -104.01% |
| Mar 31, 2019 | -16.62% |
| Dec 31, 2018 | -86.39% |